MedPath

Kappa Opioid Receptor Imaging in Anorexia

Terminated
Conditions
Anorexia Nervosa
Interventions
Other: Positron emission tomography (PET) imaging
Registration Number
NCT02240797
Lead Sponsor
NYU Langone Health
Brief Summary

The purpose of this study is to use positron emission tomography (PET) imaging and magnetic resonance imaging (MRI) to understand the brain function of individuals with anorexia nervosa and healthy controls.

Detailed Description

This is a 3-year study involving n=7 women with anorexia nervosa - recovered (AN-REC) from restricting subtype that have achieved a body mass index (BMI) \> 18.5 in the past year, are medication free, range in age from 18-55 years and n=7 healthy (medical and psychiatric statues) age- and weight-matched controls who are invited to participate in a medical and psychiatric evaluation, neuroendocrine assessments, one magnetic resonance imaging (MRI) study and one positron emission tomography (PET) study kappa opioid receptor (KOR) 11-carbon (11C) \[11C\]PKAB and PET. Subjects will be asked to provide written informed consent after full explanation of all study procedures and risks and benefits related to study participation. On the screening day a full medical evaluation including blood work, urine analyses, toxicology, electrocardiogram (ECG) and physical exam will be performed.

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
7
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Anorexia Nervosa - Recovered (AN-REC)Positron emission tomography (PET) imagingAnorexia Nervosa - Recovered (AN-REC)
Healthy Control (HC)Positron emission tomography (PET) imagingHealthy Control (HC)
Primary Outcome Measures
NameTimeMethod
Volume of distribution (VT) (i.e., KOR binding) using [11C]PKAB and PET imagingTwo months

In this study we are using the KOR radioligand \[11C\]PKAB and PET to investigate group differences in cerebral KOR binding potential in 7 AN-REC and 7 healthy controls (HCs).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

NYU School of Medicine

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath